JuliusGoldsmith
2021-11-02

$诺瓦瓦克斯医药(NVAX)$ NVAX Novavax is transitioning from a vaccine developer (R&D) to a vaccine manufacturer and commercializing it.
This is a huge step to the company, the stock will be a multi-bagger from these prices. They will start with Indonesia in the coming days. That means revenue.

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法